|
|
ORLANDO (MedPage Today) -- An experimental agent that closely mimics normal human clotting appears to rapidly curtail bleeding episodes in patients with hemophilia that is complicated by inhibitors against clotting factors, a researcher said here.
Read from Source
|
| |
| |
| | 112 |
| |
|
|
|
|
|
|
